Wave Life Sciences (WVE) Equity Ratio (2016 - 2026)
Wave Life Sciences (WVE) has disclosed Equity Ratio for 12 consecutive years, with 0.88 as the latest value for Q1 2026.
- For Q1 2026, Equity Ratio rose 47.18% year-over-year to 0.88; the TTM value through Mar 2026 reached 0.88, up 47.18%, while the annual FY2025 figure was 0.81, 36.47% up from the prior year.
- Equity Ratio hit 0.88 in Q1 2026 for Wave Life Sciences, up from 0.81 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.88 in Q1 2026 and bottomed at 0.31 in Q4 2022.
- Average Equity Ratio over 5 years is 0.23, with a median of 0.14 recorded in 2023.
- Year-over-year, Equity Ratio tumbled 40913.58% in 2023 and then surged 3414.34% in 2025.
- Wave Life Sciences' Equity Ratio stood at 0.31 in 2022, then soared by 146.79% to 0.14 in 2023, then soared by 312.71% to 0.59 in 2024, then skyrocketed by 36.47% to 0.81 in 2025, then rose by 8.02% to 0.88 in 2026.
- According to Business Quant data, Equity Ratio over the past three periods came in at 0.88, 0.81, and 0.52 for Q1 2026, Q4 2025, and Q3 2025 respectively.